Close Menu

NEW YORK (GenomeWeb) – Singapore-based Clearbridge Biomedics and Germany-based Leica Biosystems (LBS) have partnered to comarket each other's products in order support research on circulating tumor cells.

The companies will comarket Clearbridge's ClearCell CTC enrichment system and LBS' Bond Rx staining platform, creating an integrated and automated workflow for CTC enrichment and immunostaining.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers representing scientists and students of Chinese descent voice their concerns about recent US policies and rhetoric.

Wired reports that researchers have shown they could reprogram a DNA-based computer.

Researchers say increased diversity in genomic studies will benefit all, PBS NewsHour reports.

In Science this week: whole-genome sequencing of single sperm cells, and more.